Control and Prevention of Metabolic Syndrome, Renal Failure and Hepatitis C Infection

I read with great interest the article “Diabetes, renal failure and hepatitis C infection: The puzzle should be attended more in future” by SM Alavian (1). This editorial focuses its message on drawing the attention of the scientific community on emerging and increasing prevalence of the metabolic syndrome (high blood glucose, high blood pressure, abnormality in lipid profile, abdominal obesity, and fatty liver), which, if not controlled, would lead to poor consequences such as cardiovascular diseases, stroke and renal insufficiency. The editorial also demonstrated the imposing risks of hepatitis C infection in haemodialysis (HD) and kidney transplant patients, and the consequent high health and financial burden in different countries.